549 related articles for article (PubMed ID: 24997607)
1. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.
Mei F; Fancy SPJ; Shen YA; Niu J; Zhao C; Presley B; Miao E; Lee S; Mayoral SR; Redmond SA; Etxeberria A; Xiao L; Franklin RJM; Green A; Hauser SL; Chan JR
Nat Med; 2014 Aug; 20(8):954-960. PubMed ID: 24997607
[TBL] [Abstract][Full Text] [Related]
2. The best basic science paper in MS in 2013: Antimuscarinic therapies in remyelination.
Green AJ
Mult Scler; 2014 Dec; 20(14):1814-6. PubMed ID: 25392329
[No Abstract] [Full Text] [Related]
3. Neurodegenerative diseases: Pillars of remyelination.
Cully M
Nat Rev Drug Discov; 2014 Sep; 13(9):651. PubMed ID: 25145590
[No Abstract] [Full Text] [Related]
4. Development of a central nervous system axonal myelination assay for high throughput screening.
Lariosa-Willingham KD; Rosler ES; Tung JS; Dugas JC; Collins TL; Leonoudakis D
BMC Neurosci; 2016 Apr; 17():16. PubMed ID: 27103572
[TBL] [Abstract][Full Text] [Related]
5. Modeling CNS Myelination Using Micropillar Arrays.
Huang NX; Shen YA; Mei F
Methods Mol Biol; 2018; 1791():169-177. PubMed ID: 30006709
[TBL] [Abstract][Full Text] [Related]
6. A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells.
Lariosa-Willingham KD; Rosler ES; Tung JS; Dugas JC; Collins TL; Leonoudakis D
BMC Res Notes; 2016 Sep; 9(1):419. PubMed ID: 27592856
[TBL] [Abstract][Full Text] [Related]
7. Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice.
Liu J; Dupree JL; Gacias M; Frawley R; Sikder T; Naik P; Casaccia P
J Neurosci; 2016 Jan; 36(3):957-62. PubMed ID: 26791223
[TBL] [Abstract][Full Text] [Related]
8. Using Acutely Dissociated and Purified Oligodendrocyte Precursor Cells for High-Throughput Drug Screening to Identify Compounds that Promote Oligodendrocyte Differentiation.
Lariosa-Willingham K; Leonoudakis D
Curr Protoc Cell Biol; 2018 Jun; 79(1):e49. PubMed ID: 29924487
[TBL] [Abstract][Full Text] [Related]
9. Identification of the Kappa-Opioid Receptor as a Therapeutic Target for Oligodendrocyte Remyelination.
Mei F; Mayoral SR; Nobuta H; Wang F; Desponts C; Lorrain DS; Xiao L; Green AJ; Rowitch D; Whistler J; Chan JR
J Neurosci; 2016 Jul; 36(30):7925-35. PubMed ID: 27466337
[TBL] [Abstract][Full Text] [Related]
10. Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions.
Lariosa-Willingham KD; Rosler ES; Tung JS; Dugas JC; Collins TL; Leonoudakis D
BMC Res Notes; 2016 Sep; 9(1):444. PubMed ID: 27629829
[TBL] [Abstract][Full Text] [Related]
11. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
12. A regenerative approach to the treatment of multiple sclerosis.
Deshmukh VA; Tardif V; Lyssiotis CA; Green CC; Kerman B; Kim HJ; Padmanabhan K; Swoboda JG; Ahmad I; Kondo T; Gage FH; Theofilopoulos AN; Lawson BR; Schultz PG; Lairson LL
Nature; 2013 Oct; 502(7471):327-332. PubMed ID: 24107995
[TBL] [Abstract][Full Text] [Related]
13. Histamine Receptor 3 negatively regulates oligodendrocyte differentiation and remyelination.
Chen Y; Zhen W; Guo T; Zhao Y; Liu A; Rubio JP; Krull D; Richardson JC; Lu H; Wang R
PLoS One; 2017; 12(12):e0189380. PubMed ID: 29253893
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis.
Kerstetter AE; Padovani-Claudio DA; Bai L; Miller RH
Exp Neurol; 2009 Nov; 220(1):44-56. PubMed ID: 19616545
[TBL] [Abstract][Full Text] [Related]
15. High-content phenotypic screening and triaging strategy to identify small molecules driving oligodendrocyte progenitor cell differentiation.
Peppard JV; Rugg CA; Smicker MA; Powers E; Harnish E; Prisco J; Cirovic D; Wright PS; August PR; Chandross KJ
J Biomol Screen; 2015 Mar; 20(3):382-90. PubMed ID: 25394729
[TBL] [Abstract][Full Text] [Related]
16. Olesoxime accelerates myelination and promotes repair in models of demyelination.
Magalon K; Zimmer C; Cayre M; Khaldi J; Bourbon C; Robles I; Tardif G; Viola A; Pruss RM; Bordet T; Durbec P
Ann Neurol; 2012 Feb; 71(2):213-26. PubMed ID: 22367994
[TBL] [Abstract][Full Text] [Related]
17. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.
Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ
Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324
[TBL] [Abstract][Full Text] [Related]
18. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
Mi S; Miller RH; Tang W; Lee X; Hu B; Wu W; Zhang Y; Shields CB; Zhang Y; Miklasz S; Shea D; Mason J; Franklin RJ; Ji B; Shao Z; Chédotal A; Bernard F; Roulois A; Xu J; Jung V; Pepinsky B
Ann Neurol; 2009 Mar; 65(3):304-15. PubMed ID: 19334062
[TBL] [Abstract][Full Text] [Related]
19. Selective Estrogen Receptor Modulators Enhance CNS Remyelination Independent of Estrogen Receptors.
Rankin KA; Mei F; Kim K; Shen YA; Mayoral SR; Desponts C; Lorrain DS; Green AJ; Baranzini SE; Chan JR; Bove R
J Neurosci; 2019 Mar; 39(12):2184-2194. PubMed ID: 30696729
[TBL] [Abstract][Full Text] [Related]
20. Local delivery of thyroid hormone enhances oligodendrogenesis and myelination after spinal cord injury.
Shultz RB; Wang Z; Nong J; Zhang Z; Zhong Y
J Neural Eng; 2017 Jun; 14(3):036014. PubMed ID: 28358726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
